High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis

High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis

Background This study aimed to determine whether a shorter high-dose rifampicin regimen is non-inferior to the standard 6-month tuberculosis regimen. Methods This multicenter, randomized, open-label, non-inferiority trial enrolled participants with respiratory specimen positivity by Xpert MTB/RIF as...

Full description

Saved in:
Bibliographic Details
Main Authors: Nakwon Kwak, Joong-Yub Kim, Hyung-Jun Kim, Byoung-Soo Kwon, Jae Ho Lee, Jeongha Mok, Yong-Soo Kwon, Young Ae Kang, Youngmok Park, Ji Yeon Lee, Doosoo Jeon, Jung-Kyu Lee, Jeong Seong Yang, Jake Whang, Kyung Jong Kim, Young Ran Kim, Minkyoung Cheon, Jiwon Park, Seokyung Hahn, Jae-Joon Yim
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2025-01-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
high-dose rifampicin
tuberculosis
treatment shortening
Online Access:http://e-trd.org/upload/pdf/trd-2024-0099.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://e-trd.org/upload/pdf/trd-2024-0099.pdf

Similar Items